A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients

This study has been terminated.

( See termination reason in detailed description. )

Study NCT00391196 Information provided by Pfizer

First Received: October 19, 2006 Last Updated: October 27, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	January 2009
Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)